Within the recent second international consensus report from the Precision Medicine in Diabetes Initiative (PMDI), published in Nature Medicine, researchers summarized systematic reviews and consensus among the many PMDI consortium on precision medicine for prevention, diagnosis, treatment, and prognosis for monogenic (MDM), gestational (GDM), type 1 (T1D), and kind 2 (T2D) diabetes mellitus. Study: Second international […]
Tag Archives: Breakthrough
Findings from a brand new medical trial, recently published in a prestigious scientific journal, may significantly improve life outcomes for patients with high-risk myeloma. Myeloma affects bone marrow cells and is a relapsing and remitting cancer that has a major physical and emotional burden on patients and their families. Despite significant advances in treatment and […]
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in collaboration with Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University Singapore (NTU Singapore) and Massachusetts Institute of Technology (MIT), have discovered a brand new stress signaling system that […]